Lithium Level Drawn 1 Hour Post-Dose: Expected Value
The serum lithium level drawn 1 hour after the morning dose will be significantly elevated above therapeutic range—likely 1.5-2.5 times higher than the standard 12-hour trough level—representing a peak concentration rather than a clinically useful measurement.
Why This Timing is Problematic
Lithium pharmacokinetics show that peak serum concentrations occur at 1-2 hours after standard-release formulations 1, 2. At this 1-hour timepoint, you're capturing the drug during its absorption and distribution phase, not at steady-state. This makes the result essentially uninterpretable for clinical decision-making.
Expected Serum Level Range
For a patient on 600 mg BID (1200 mg total daily):
- At 1 hour post-dose: Expect approximately 1.2-2.0 mEq/L or higher (peak level)
- At proper 12-hour timing: Would typically be 0.6-1.2 mEq/L (therapeutic trough)
The 1-hour level will be falsely elevated by 50-100% compared to the standard 12-hour level 2, 3.
Critical Clinical Implications
Do not use this level to guide dosing decisions. The FDA label explicitly states: "Blood samples for serum lithium determination should be drawn immediately prior to the next dose when lithium concentrations are relatively stable (i.e., 8-12 hours after the previous dose)" 1.
What To Do Now:
- Redraw the level correctly: Obtain blood sample 12 hours after the last dose (before the morning dose if on BID dosing)
- Do not adjust the dose based on this 1-hour level
- Monitor for toxicity clinically: Even though the timing is wrong, if the level is >2.0 mEq/L at 1 hour, this suggests potential for toxicity and warrants clinical assessment 1
Proper Monitoring Protocol
According to FDA labeling and guidelines 1, 4:
- Acute phase: Check levels twice weekly until stable
- Maintenance: Every 2 months minimum, plus every 6 months for renal/thyroid function 5
- Target therapeutic range: 0.6-1.2 mEq/L for maintenance (measured at 12 hours post-dose) 1, 6
Common Pitfall Highlighted Here
This scenario represents a frequent laboratory error where blood is drawn at medication administration time rather than before the next dose. Recent research has attempted to develop correction equations for mistimed levels 7, but the most reliable approach remains proper timing of the blood draw at 12 hours post-dose 8.
The bottom line: This 1-hour level is clinically useless for therapeutic monitoring. Repeat the draw at the correct 12-hour timepoint before making any dosing adjustments.